Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TMO vs GSK✓SelectedUSD · GSKTMO vs GSK performance historyLatest closeAs of-2.79%11/20
Stock and ETF performance explorer

TMO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+371.2%
GSK return
+97.4%
Excess return
+273.8%
Maximum drawdown
-41.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.8%-0.1%-2.7%-2.7%
7D-4.4%-5.3%+1.0%-2.3%
30D-3.5%-3.7%+0.1%-2.3%
3M+6.8%-7.3%+14.0%+9.7%
6M+48.5%-4.2%+52.7%+49.9%
YTD+15.9%+0.9%+15.0%+13.7%
1Y+17.3%+7.3%+10.0%+12.2%
3Y+44.1%+52.7%-8.6%+16.3%
5Y+6.8%+40.1%-33.3%-11.9%
All+371.2%+97.4%+273.8%+213.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling